Bank of America’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.1M | Buy |
508,987
+83,107
| +20% | +$3.61M | ﹤0.01% | 2132 |
|
2025
Q1 | $15.9M | Buy |
425,880
+320,340
| +304% | +$12M | ﹤0.01% | 2320 |
|
2024
Q4 | $4.78M | Sell |
105,540
-193,932
| -65% | -$8.79M | ﹤0.01% | 3072 |
|
2024
Q3 | $17.6M | Sell |
299,472
-50,084
| -14% | -$2.94M | ﹤0.01% | 2174 |
|
2024
Q2 | $13.8M | Sell |
349,556
-47,222
| -12% | -$1.86M | ﹤0.01% | 2283 |
|
2024
Q1 | $26.4M | Sell |
396,778
-92,431
| -19% | -$6.14M | ﹤0.01% | 1744 |
|
2023
Q4 | $13.7M | Buy |
489,209
+468,639
| +2,278% | +$13.1M | ﹤0.01% | 2127 |
|
2023
Q3 | $438K | Buy |
+20,570
| New | +$438K | ﹤0.01% | 4567 |
|